Citadel Advisors’s Oak Street Health, Inc. OSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-101,000
Closed -$3.91M 15734
2023
Q1
$3.91M Sell
101,000
-22,600
-18% -$729K ﹤0.01% 4207
2022
Q4
$2.66M Buy
123,600
+23,500
+23% +$492K ﹤0.01% 4957
2022
Q3
$2.45M Sell
100,100
-458,100
-82% -$12.1M ﹤0.01% 5193
2022
Q2
$9.18M Buy
558,200
+287,200
+106% +$5.58M ﹤0.01% 2803
2022
Q1
$7.28M Buy
271,000
+56,000
+26% +$1.18M ﹤0.01% 3481
2021
Q4
$7.13M Sell
215,000
-786,600
-79% -$29.8M ﹤0.01% 3681
2021
Q3
$42.6M Buy
1,001,600
+346,700
+53% +$18.6M 0.01% 1260
2021
Q2
$38.4M Buy
654,900
+629,700
+2,499% +$37.5M 0.01% 1354
2021
Q1
$1.37M Buy
25,200
+14,800
+142% +$823K ﹤0.01% 7340
2020
Q4
$636K Buy
+10,400
New +$546K ﹤0.01% 7699

Other funds holding OSH

Citadel Advisors's OSH Position: Q2 2023 in Review

Citadel Advisors sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 1,587,371 shares — an estimated $61.4M sold.

Citadel Advisors first reported a position in OSH in Q3 2020 and held it in 10 quarters. The position peaked at $61.4M in Q1 2023. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

  • Citadel Advisors reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 1,587,371 Oak Street Health, Inc. shares in Q2 2023, an estimated $61.4M.
  • Citadel Advisors first reported a position in Oak Street Health, Inc. in Q3 2020 and held it in 10 quarters.
  • Citadel Advisors's Oak Street Health, Inc. position peaked at $61.4M in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.